鑫达医学翻译公司-最好的医学翻译、病历翻译、药学翻译、sci论文翻译、生物翻译网站!您最好的医学论文翻译合作伙伴!
设为首页 | 加入收藏 | 联系我们
首页 > 医学翻译 >

肾病药物使用相关翻译

发布者:鑫达医学翻译 发布时间:2013-05-22 8:50:52 阅读:
原文:
Benefits of prednisolone and chlorambucil were maintained for at least 3 years of follow-up. Delaying end-stage renal disease, with its associated cardiovascular risk and increased morbidity and mortality, is of undoubted value to patients with idiopathic membranous nephropathy. However, even in patients given prednisolone and chlorambucil, only 40% had not had a further 20% decline in excretory renal function at 3 years. Clearly, more effective and safer forms of therapy are still needed for idiopathic membranous nephropathy. Until new treatments are available and have been properly tested, the evidence favours use of prednisolone and an alkylating agent in the most severely affected patients. This conclusion, and the lack of good RCTs in nephrology to address this and similar questions, are supported by a Cochrane review of the subject26 and an authoritative review of the international scientific literature on the treatment of glomerulonephritis (panel).
 
译文:
泼尼松龙和苯丁酸氮芥的疗效在接下来至少3年内得到维持。对晚期肾病(及相关的心血管疾病风险和增加的发病率和死亡率)的推迟,无疑对特发性膜性肾病患者具有价值。然而,即使在泼尼松龙与苯丁酸氮芥给药的患者中,只有40%的患者在3年内肾功能下降不超过20%。显然对于特发性膜性肾病,还需要更加有效和安全的治疗方式。在出现新疗法并验证其疗效前,对于多数重症患者,临床证据更倾向于使用泼尼松龙与烷化剂。此结论,以及在肾脏学领域解决此类及类似问题缺乏良好的RCT这一情况,都得到了循证医学关于此课题的综述和另一篇在国际科学文献上关于肾小球性肾炎治疗的权威综述的支持(附注)。

鑫达医学翻译公司本着“专业、专注、诚信、共赢”的原则,旨在为广大客户提供生物学、医学、药学材料的口译与笔译,业务范围为医学英语翻译病历翻译医学文献翻译药学翻译医疗器材翻译医疗器械翻译SCI医学论文翻译写作与投稿,宣传册制作,项目申报材料及医疗类中英文网站的建设工作。
联系方式

免费咨询电话:400-6870-112
传真:0531-88956115
地址:山东省济南市高新区舜华路2000号舜泰广场6号楼27层CD区
邮箱: trans@xdtrans.com